Core One Labs Inc. (CLABF)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Mar 4, 2026
Core One Labs Revenue
In the fiscal year ending March 31, 2023, Core One Labs had annual revenue of 458.54K CAD, down -29.25%. Core One Labs had revenue of 93.66K in the quarter ending December 31, 2023, a decrease of -17.22%.
Revenue
458.54K CAD
Revenue Growth
-18.65%
P/S Ratio
0.00
Revenue / Employee
n/a
Employees
n/a
Market Cap
47.00 USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2023 | 458.54K | -189.55K | -29.25% |
| Dec 31, 2022 | 648.09K | 216.47K | 50.15% |
| Dec 31, 2021 | 431.62K | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | - | - | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Gelesis Holdings | 12.14M |
| Genocea Biosciences | 1.91M |
| Baudax Bio | 1.27M |
| Mymetics | 564.14K |
| Bioasis Technologies | 199.01K |
| Panacos Pharmaceuticals | 99.00K |
| Athersys | 80.00K |